Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Parkinson’s Drug Awaits OK While ADHD Lifts Impax Now
Aug. 17, 2012
While its long-awaited novel drug to treat Parkinson’s disease inches closer to the finish line, Impax Laboratories has found other ways to keep its growth engine humming.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing